News
Covid-19: Coalition pledges $42m to develop broad protection vaccine against betacoronaviruses
BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o628 (Published 09 March 2022) Cite this as: BMJ 2022;376:o628
- Elisabeth Mahase
- The BMJ
The Coalition for Epidemic Preparedness Innovations (CEPI) has pledged up to $42m to support the development of a vaccine that could provide broad protection against SARS-CoV-2 as well as other betacoronaviruses including severe acute respiratory syndrome and Middle East respiratory syndrome.
The vaccine development is being led by biotech company DIOSynVax—which came out of the University of Cambridge. Unlike most other covid-19 vaccines, DIOSynVax is not focusing on the SARS-CoV-2 spike protein as this is vulnerable …